Genesis Therapeutics is building a worldclass software team to solve problems in drug discovery through machine learning biophysical simulation and computational chemistry. We are looking for engineers excited to help develop new medicines and play a critical role in building out our software platform.
You will
Build and maintain complex computational chemistry workflows for drug discovery
Work closely with computational chemists and CADD scientists to productionize new computational methods for molecular property prediction
Help scale our data infrastructure to handle billions of datapoints and hundreds of thousands of parallel QM and molecular dynamics jobs
You are
A deep thinker who reasons from first principles balances attention to detail with architectural thinking and has an investigational curiosity to find the root cause of a problem
Comfortable working across all levels of the software stack building intuitive APIs and libraries for computational chemists
Experienced working in the fields of computational chemistry and drug discovery
Experienced writing production code and driving projects to completion
What we offer
The opportunity to work on high impact tools and products that are immediately deployed to accelerate the discovery of new medicines
Strong technical coworkers in AI software and chemistry who all have a powerful mix of intellectual curiosity and humility. The team reads and discusses 12 machine learning or chemistry papers every week to stay on top of the field and inspire new ideas
Competitive salary and equity. Medical dental and vision insurance and a 401(k) program
Our team has created the industrys most advanced molecular AI platform called GEMS (Genesis Exploration of Molecular Space) to accelerate and optimize small molecule drug discovery and to enable the discovery of novel firstinclass and bestinclass small molecule for challenging and/or undruggable targets.
The company has leveraged GEMS to build an internal pipeline with multiple programs against highvalue targets including datapoor and canonically undruggable targets where GEMS is uniquely advantaged. In addition Genesis has signed AIfocused platform collaborations with major pharmaceutical companies including most recently Incyte Corporation (Feb 2025 and Gilead Sciences (Sept 2024.
We raised a $200M series B in August 2023 and have raised over $300M in funding from top technology and biotech investors including Andreessen Horowitz Rock Springs Capital T. Rowe Price Fidelity Radical Ventures NVentures (NVIDIAs VC arm) BlackRock and Menlo Ventures.
Genesis is headquartered in Burlingame CA with a fully integrated laboratory in San Diego. We are proud to be an inclusive workplace and an Equal Opportunity Employer.
Disclaimer: Drjobpro.com is only a platform that connects job seekers and employers. Applicants are advised to conduct their own independent research into the credentials of the prospective employer.We always make certain that our clients do not endorse any request for money payments, thus we advise against sharing any personal or bank-related information with any third party. If you suspect fraud or malpractice, please contact us via contact us page.